Black Rock Inc. Sio Gene Therapies Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.28 - $0.44 $1 - $3	-7 Reduced -0.0%	390,386 $171,000
Q3 2022 Nov 14, 2022	BUY	$0.28 - $0.41 $1 - $2	7 Added 0.0%	390,393 $109,000
Q2 2022 Aug 12, 2022	SELL	$0.25 - $0.73 $33,434 - $97,628	-133,737 Reduced 25.52%	390,386 $141,000
Q1 2022 May 12, 2022	SELL	$0.55 - $1.47 $3,603 - $9,631	-6,552 Reduced 1.23%	524,123 $352,000
Q4 2021 Feb 10, 2022	BUY	$1.29 - $2.36 $501,014 - $916,583	388,383 Added 272.95%	530,675 $685,000
Q3 2021 Nov 09, 2021	BUY	$1.81 - $2.7 $44,495 - $66,374	24,583 Added 20.88%	142,292 $309,000
Q2 2021 Aug 11, 2021	BUY	$2.07 - $2.89 $243,657 - $340,179	117,709 New	117,709 $321,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.